Navigation Links
Antibody therapy lengthens survival of metastatic melanoma patients in large clinical trial
Date:6/7/2010

CHICAGOA therapy that multiplies the effect of a natural disease-fighting antibody has extended the lives of patients with metastatic melanoma in a large, international clinical trial. The study's researchers will report their findings simultaneously at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago and in the New England Journal of Medicine.

Patients in the phase III clinical study who received the drug ipilimumab a monoclonal antibody made by duplicating a single type of human antibody thousands of times over survived for an average of 10 months whether they received the drug alone or in combination with a therapeutic vaccine known as gp100, compared to just over six months for those who received gp100 alone, investigators found. The four-month difference represents a 67 percent increase in survival time between the two groups. And because it occurred in patients who were otherwise out of treatment options all of them having metastatic disease that spread even after earlier treatment the treatment demonstrates the promise of monoclonal antibody treatment for cancer patients not helped by conventional therapies, the study authors say.

F. Stephen Hodi, MD, director of the melanoma treatment center at Dana-Farber Cancer Institute and co-first author of the paper, says the findings are significant on two levels. "It is the first study to show a survival benefit for metastatic melanoma, which is often a fatal disease, and it is proof that this first-in-class treatment is effective in cancer."

The study (Abstract 4) will be presented in a plenary session at ASCO on Sunday, June 6, 1-4 pm, N Hall, Room B1, and will be posted on the Internet in advance of print publication by the New England Journal of Medicine.

The number of cases of metastatic melanoma considered the most serious form of skin cancer has increased during the past 30 years, and its death rate is rising faster than mo
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-233-5507
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Antibody-guided drug shows encouraging activity in metastatic breast cancer
2. Fox Chase clinical trial tests first of its kind antibody
3. Targeted therapy prolongs life in patients with HER2-positive breast cancer
4. PharmMD Secures Investments to Fund New Opportunities in Medication Therapy Management
5. More smokers kick the habit with extended nicotine patch therapy, Penn research shows
6. Experts Issue Warning on Prostate Hormone Therapy
7. ASGCT: Gene Therapy Shows Promise for Patients with Pompe Disease
8. AAPM statement on quality radiation therapy
9. Congress Urged to Take Immediate Action to Ensure Frail Patients Continue to Receive Critical Therapy Services
10. Intensive Insulin Therapy Wont Boost Septic Shock Survival
11. News brief: Dermatologic infections in cancer patients treated with EGFRI therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 Mountain Point Medical Center, ... ribbon cutting ceremony on Friday, May 29, 2015 at 11 ... 6 p.m. The new medical center, set to officially open ... Boulevard, Lehi, UT 84043. , “The opening of Mountain ... and the Utah County community,” said Kent Loosle, CEO of ...
(Date:5/22/2015)... May 22, 2015 Omar Ahmad Barrada, ... to participate in the 2015 Congress of Future Medical ... as a gathering of “America’s highest achieving high school ... of healthcare, set new goals and learn better study ... live surgery, during which we can ask the surgeons ...
(Date:5/22/2015)... 22, 2015 Family, friends, students, colleagues, ... surgical oncologist, Dr. LaSalle D. Leffall, on Monday, May ... began after Grand Rounds in the hospital’s Tower Auditorium. ... outside the auditorium, trying to keep the secret. “I’d ... he sees me, he’ll know something is up,” she ...
(Date:5/22/2015)... 22, 2015 According to a new Aegis ... are equally as likely to worry about what will happen ... X, 77% Boomers, 69% Silent Generation), which may help explain ... scared of aging, particularly Millennials (47%), Gen X’ers (51%), and ... in April, 2015 among more than 2,000 U.S. adults ages ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 According to ... hub for drug related death, totaling almost 2,500 confirmed drug ... reported by state officials, totals 2,489 deaths stemming from legal ... out, Pennsylvania loses seven people every day to fatal overdoses ... been singled out as one of the most rife with ...
Breaking Medicine News(10 mins):Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2
... at the Salk Institute for Biological Studies, fisetin, a ... fruits and vegetables, invigorates signaling pathways that boost long-term ... week’s Online Early Edition of the Proceedings of the ... in over 30% of the people aged 60 and ...
... in US have come up with a heady option that ... in brain cells often after an episode of stroke or ... John Hopkins University ,who conducted a study on mice, ... the skin of red grapes, administered in moderate doses, showed ...
... three sisters Julie Owen, Pam Dugmore and Rosemary Moss at ... which determined// whether they were carriers of a mutated gene ... of developing breast cancer. ,The results revealed that ... gene. Only Rosemary, 64, did not. The sisters were advised ...
... who are gluten intolerant run four times the risk of ... print in Thorax. // ,Gluten intolerance, or ... bowel, caused by an exaggerated immune response to the gluten ... up to 1% of the population, and has been linked ...
... supplements for good health despite the fact that few actually ... the best way to stay healthy is a balanced diet. ... worried that food has fewer nutrients than it used to, ... is freshly picked produce, reported the online edition of Daily ...
... the fatal lung disease; Chronic Obstructive Pulmonary Disease (COPD) ... smokers//. ,Chronic bronchitis and emphysema constitute COPD, ... globe. Cough, fatigue, shortness of breath and subsequent difficulty ... ,The scientists at the Hvidovre Hospital in Denmark conducted ...
Cached Medicine News:Health News:Eating Strawberries may boost memory 2Health News:Eating Strawberries may boost memory 3Health News:A Family's Fight against Breast cancer 2Health News:A Family's Fight against Breast cancer 3Health News:Madhya Pradesh Tops in Implementing Child Health Scheme 2
(Date:5/22/2015)... KING OF PRUSSIA, Pa. , May 22, 2015 ... CSL Behring its 2015 Corporate Leadership Award as ... science and improving the care of the bleeding disorders community.  ... and Managing Director, CSL Limited, during the NHF Annual Spring ... May 21. "The National Hemophilia Foundation is dedicated ...
(Date:5/22/2015)... InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), ... that its CGuard TM Embolic Prevention System reported positive ... Musialek , at the EuroPCR conference on May ... PARADIGM, an investigator-initiated P rospective evaluation of ... revascularization I n symptomatic and increased-risk asymptomatic carotid artery ...
(Date:5/22/2015)... 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... executive officer Howie Rosen will be presenting ... Tim Morris will be presenting at JMP ... are as follows: Jefferies 2015 Healthcare Conference ...
Breaking Medicine Technology:National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2
... Medical Affiliates, Inc. (Pink Sheets: UCIA ) today announced ... the quarter ended June 30, 2010. Revenues for the ... or 9.23% over revenues of $19,264,467 for the quarter ended June ... the quarter ended June 30, 2010 compared to net income of ...
... is pleased to announce that Robert R. Bulger, M.D. ... of minimally invasive back pain treatment techniques.  The ... a variety of conditions responsible for back pain on ... American Spine,s trained physicians are the only doctors performing ...
Cached Medicine Technology:UCI Medical Affiliates, Inc. Reports Third Quarter Results for Fiscal Year 2010 2UCI Medical Affiliates, Inc. Reports Third Quarter Results for Fiscal Year 2010 3UCI Medical Affiliates, Inc. Reports Third Quarter Results for Fiscal Year 2010 4North American Spine Welcomes Robert R. Bulger, M.D. to Dallas Physician Group 2North American Spine Welcomes Robert R. Bulger, M.D. to Dallas Physician Group 3
Inquire...
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
Medicine Products: